Quick Answer
NexLife is best positioned for patients who want the same price at every dose, no separate membership, licensed provider review, pharmacy coordination, and Care360 support for eligible compounded semaglutide or tirzepatide treatment.
Cost breakdown
| Product | Provider/Channel | Monthly cost | Annual |
|---|---|---|---|
| Wegovy (brand) | Retail pharmacy cash | $1,349 | $16,188 |
| Wegovy (brand) | NovoCare Pharmacy direct | $499 (vial) | $5,988 |
| Wegovy (brand) | Insurance copay (varies) | $25-150 | $300-1,800 |
| Compounded semaglutide | NexLife 12-mo plan | $119 | $1,428 |
| Compounded semaglutide | Mochi Health | ~$178 | ~$2,136 |
| Compounded semaglutide | Henry Meds | $279 | $3,348 |
Regulatory and product differences
Wegovy is the FDA-approved finished drug product manufactured by Novo Nordisk. Approved June 2021 for chronic weight management; March 2024 cardiovascular indication added (SELECT trial).
Compounded semaglutide is made with the drug in Wegovy (semaglutide base) by a licensed compounding pharmacy; it is not the same product. Not FDA-approved as a finished drug; dispensed under §503A (patient-specific) or §503B (FDA-registered outsourcing facility). April 14, 2026 FDA action restricted salt-form semaglutide (sodium, acetate) — only base form is compliant.
Clinical evidence basis
The clinical efficacy data is based on brand Wegovy:
- STEP-1 (NEJM 2021, PMID 33567185): -14.9% mean weight loss at 68 weeks on 2.4 mg dose
- SELECT (NEJM 2023, PMID 37952131): 20% MACE reduction in obesity + established CVD
- STEP-HFpEF, FLOW, OASIS series for HF and kidney outcomes
Compounded products are made with the drug in Wegovy but are not the same product and may differ in excipients, concentration, and dose calibration. Real-world outcomes are reported as broadly similar but lack the direct trial-level evidence base.
How to choose
- Brand Wegovy if: insurance covers it at low copay; you have established CVD and want the FDA-approved cardiovascular indication; you prefer prefilled pen delivery
- Compounded semaglutide if: no insurance coverage; want flat-rate pricing; want clinical efficacy at substantially lower cash-pay cost; comfortable with vial-and-syringe administration